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International standards for fetal growth based on serial 
ultrasound measurements: the Fetal Growth Longitudinal 
Study of the INTERGROWTH-21st Project
Aris T Papageorghiou, Eric O Ohuma, Douglas G Altman, Tullia Todros, Leila Cheikh Ismail, Ann Lambert, Yasmin A Jaffer, Enrico Bertino, 
Michael G Gravett, Manorama Purwar, J Alison Noble, Ruyan Pang, Cesar G Victora, Fernando C Barros, Maria Carvalho, Laurent J Salomon, 
Zulfiqar A Bhutta*, Stephen H Kennedy*, José Villar*, for the International Fetal and Newborn Growth Consortium for the 21st Century 
(INTERGROWTH-21st)†
Summary
Background In 2006, WHO produced international growth standards for infants and children up to age 5 years on the 
basis of recommendations from a WHO expert committee. Using the same methods and conceptual approach, the 
Fetal Growth Longitudinal Study (FGLS), part of the INTERGROWTH-21st Project, aimed to develop international 
growth and size standards for fetuses.
Methods The multicentre, population-based FGLS assessed fetal growth in geographically defined urban populations 
in eight countries, in which most of the health and nutritional needs of mothers were met and adequate antenatal 
care was provided. We used ultrasound to take fetal anthropometric measurements prospectively from 14 weeks and 
0 days of gestation until birth in a cohort of women with adequate health and nutritional status who were at low risk 
of intrauterine growth restriction. All women had a reliable estimate of gestational age confirmed by ultrasound 
measurement of fetal crown–rump length in the first trimester. The five primary ultrasound measures of fetal 
growth—head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur 
length—were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. The best 
fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in 
a multilevel framework to account for the longitudinal design of the study.
Findings We screened 13 108 women commencing antenatal care at less than 14 weeks and 0 days of gestation, of 
whom 4607 (35%) were eligible. 4321 (94%) eligible women had pregnancies without major complications and 
delivered live singletons without congenital malformations (the analysis population). We documented very low 
maternal and perinatal mortality and morbidity, confirming that the participants were at low risk of adverse outcomes. 
For each of the five fetal growth measures, the mean differences between the observed and smoothed centiles for the 
3rd, 50th, and 97th centiles, respectively, were small: 2·25 mm (SD 3·0), 0·02 mm (3·0), and –2·69 mm (3·2) for 
head circumference; 0·83 mm (0·9), –0·05 mm (0·8), and –0·84 mm (1·0) for biparietal diameter; 0·63 mm (1·2), 
0·04 mm (1·1), and –1·05 mm (1·3) for occipitofrontal diameter; 2·99 mm (3·1), 0·25 mm (3·2), and –4·22 mm 
(3·7) for abdominal circumference; and 0·62 mm (0·8), 0·03 mm (0·8), and –0·65 mm (0·8) for femur length. We 
calculated the 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound 
measures, representing the international standards for fetal growth.
Interpretation We recommend these international fetal growth standards for the clinical interpretation of routinely 
taken ultrasound measurements and for comparisons across populations.
Funding Bill & Melinda Gates Foundation.
Introduction
Screening for disturbances in fetal growth is one of the 
main purposes of antenatal care. None of the biomarkers 
assessed so far can accurately predict fetal growth 
restriction;1 therefore, screening relies on routine 
measurement of uterine fundal height, complemented 
by ultrasound measurement of fetal size in women with 
pregnancy complications or with a relevant history or 
clinical evidence of fetal growth restriction.
Despite the widespread use of ultrasound worldwide, 
concerns have been expressed about the low detection 
rates of abnormal fetal growth in routine practice,2,3 even 
when used mostly in high-risk subpopulations. However, 
these observations should be interpreted with caution in 
view of the large number of locally derived reference 
charts available4 and the absence of suitable international 
standards similar to the standards used for monitoring 
infant growth.5 Additionally, large variation is seen in the 
cutoff points (eg, 3rd, 5th, or 10th centile) used to 
establish whether fetal growth is abnormal, even within 
the same population or region.4 The use of such a range 
of charts and cutoff points4,6 in clinical decision making 
about fetal growth patterns inevitably leads to diagnostic 
confusion, difficulties comparing outcomes across 
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populations, and unnecessary anxiety for mothers and 
their families.
International standards are urgently needed because, 
unlike for the neonatal period, none are available to 
enable fetal growth to be monitored as recommended 
by WHO.7 The aim of the Fetal Growth Longitudinal 
Study (FGLS)—part of the International Fetal and 
Newborn Growth Consortium for the 21st Century 
(INTERGROWTH-21st) Project—was to construct such 
standards for fetal growth, adopting the same approach 
and methods as the WHO Multicentre Growth 
Reference Study (MGRS)8 by studying a cohort of 
healthy, well nourished, pregnant women from 
eight geographically diverse populations who were at 
low risk of adverse maternal and perinatal outcomes.9,10
Methods
Study design and participants
INTERGROWTH-21st is a multicentre, multiethnic, 
population-based project done between April 27, 2009, 
and March 2, 2014, in eight sites in eight countries: 
Pelotas, Brazil; Turin, Italy; Muscat, Oman; Oxford, UK; 
Seattle, WA, USA; Shunyi County, a suburban district of 
the Beijing municipality, China; the central area of the 
city of Nagpur (Central Nagpur), Maharashtra, India; and 
the Parklands suburb of Nairobi, Kenya.9 The 
INTERGROWTH-21st Project’s main aim was to study 
growth, health, nutrition and neurodevelopment from 
less than 14 weeks and 0 days of gestation to 2 years of 
age, using the same conceptual framework as the WHO 
MGRS,8 so as to produce prescriptive growth standards to 
complement the existing WHO Child Growth Standards,5 
and to develop a new phenotypic classification of the fetal 
growth restriction and preterm birth syndromes.
FGLS is one of the three main studies of the 
INTERGROWTH-21st Project, which has been described 
in detail elsewhere.9 Briefly, the populations that 
contributed participants to the project were first selected at 
the geographical level and then at the individual level 
within each study site. At the population level, we identified 
an urban area (a complete city or county, or part of a city 
with clear political or geographical limits) where most 
deliveries occurred in health facilities. The areas had to be 
located at an altitude of 1600 m or lower and women 
receiving antenatal care had to plan to deliver in these 
facilities or in a similar hospital located in the same 
geographical area. Furthermore, the area had to be free or 
have low levels of major, known, non-microbiological 
contamination such as pollution, domestic smoke due to 
tobacco smoking or cooking, radiation, or any other toxic 
substances.11 At each of the eight study sites, we selected all 
facilities providing antenatal and intrapartum care where 
more than 80% of deliveries in those urban areas occurred.
At each study site we recruited women with the 
characteristics required for FGLS—ie, women with no 
clinically relevant obstetric, gynaecological, or medical 
history who initiated antenatal care before 14 weeks of 
gestation (measured by menstrual dates) and met the 
entry criteria of optimal health, nutrition, education, and 
socioeconomic status. A detailed description of the entry 
criteria and definitions has been published previously.9 
For example, adequate nutritional status was defined in 
the first trimester according to maternal height (≥153 cm), 
body-mass index (BMI; ≥18·5 and <30 kg/m²), and 
haemoglobin concentration (≥110 g/L), and whether the 
mother was receiving treatment for anaemia or following 
any special diets—eg, vegetarian with no animal 
products. This resulted in a group of educated, affluent, 
clinically healthy women, with adequate nutritional 
status, who by definition were at low risk of fetal growth 
restriction and preterm birth. 
The INTERGROWTH-21st Project was approved by the 
Oxfordshire Research Ethics Committee “C” (reference: 
08/H0606/139), the research ethics committees of the 
individual participating institutions, and the corres-
ponding regional health authorities where the project 
was implemented. Participants provided written consent 
to be involved in the study.
Procedures
The last menstrual period (LMP) was used to calculate 
gestational age provided that the LMP date was certain; 
the woman had a regular 24–32 day menstrual cycle; she 
had not been using hormonal contraception or 
breastfeeding in the preceding 2 months; and any 
discrepancy between the gestational ages based on LMP 
and crown–rump length (CRL), measured by ultrasound 
between 9 weeks and 0 days and 13 weeks and 6 days after 
the LMP, was 7 days or less, using the formula described 
by Robinson and Fleming.12 To ensure that CRL measures 
were interpreted consistently, the Robinson and Fleming 
formula was loaded into all the study ultrasound 
machines; whenever another machine had to be used 
locally for CRL measurement, a conversion table extracted 
from the same formula was provided. The CRL technique 
was also standardised across sites and all 
ultrasonographers were trained uniformly.13
We scanned women every 5 weeks (within 1 week 
either side) after the initial dating scan, so that the 
possible ranges after the dating scan were 14–18, 19–23, 
24–28, 29–33, 34–38, and 39–42 weeks of gestation. At 
each visit, fetal head circumference, biparietal diameter, 
occipitofrontal diameter, abdominal circumference, and 
femur length were measured three times from 
three separately obtained ultrasound images of each 
structure. The detailed measurement protocol and the 
unique standardisation procedures have been reported 
elsewhere,14 and all documentation, protocols, data 
collection forms, and electronic transfer strategies are 
freely available on the INTERGROWTH-21st website.
Briefly, head measurements were taken in an axial view 
at the level of the thalami, with an angle of insonation as 
close as possible to 90°. The head had to be oval in shape, 
symmetrical, centrally positioned, and filling at least 30% 
For the INTERGROWTH-21st 
website see www.
intergrowth21.org
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of the monitor. The midline echo (representing the falx 
cerebri) had to be broken anteriorly, at a third of its length, 
by the cavum septi pellucidi. The thalami had to be located 
symmetrically on either side of the midline. Callipers 
were then placed on the outer border of the parietal bones 
(outer to outer) at the widest or longest part of the skull for 
the biparietal diameter and occipitofrontal diameter, 
respectively; the head circumference was measured using 
the ellipse facility on the outer border of the skull.
The measurements of the abdomen were taken in a 
cross-sectional view of the fetal abdomen as close as 
possible to circular, with the umbilical vein in the anterior 
third of the abdomen (at the level of the portal sinus), 
with the stomach bubble visible. The operator was 
instructed to avoid applying too much pressure with the 
transducer, which can distort the circular shape of the 
fetal abdomen. The abdomen had to fill at least 30% of 
the monitor screen, preferably, and the spine had to be at 
either a 3 o’clock or 9 o’clock position to avoid internal 
shadowing; the kidneys and bladder had not to be visible. 
For the measurements, the contour of the ellipse was 
placed on the outer border of the abdomen.
Recognising that the head and abdomen are elliptical 
in shape, in addition to measurements of head 
circumference and abdominal circumference obtained 
using the ellipse facility of the ultrasound machine, head 
circumference and abdominal circumference were also 
estimated from the lengths of the two directly measured 
diameters (major and minor axes). Because no explicit 
(closed form) formula exists to calculate the 
circumference of an ellipse from the diameters, common 
approximations are used, based on the formula for a 
circle. These approximations tend to be more accurate 
when the two diameters are similar, especially when the 
ratio of biparietal diameter to occipitofrontal diameter is 
about 1; however, when this ratio is less than 0·8 it can 
lead to bias. Therefore, we calculated head circumference 
and abdominal circumference using an exact formula 
derived from the elliptical integral (appendix).
Finally, the femur length was measured using a 
longitudinal view of the fetal thigh closest to the probe 
and with the femur as close as possible to the horizontal 
plane. The angle of insonation of the ultrasound beam 
was about 90°, with the full length of the bone visualised, 
unobscured by shadowing from adjacent bony parts, and 
the femur had to fill at least 30% of the monitor screen. 
The intersection of the callipers was placed on the outer 
borders of the edges of the femoral diaphysis (outer to 
outer) ensuring clear femoral edges; ultrasound artefacts 
of the femoral edges such as the proximal trochanter or 
pointed femoral spurs were not included in the 
measurement (detailed methods and a graphical display 
of how the bone structures are localised are available on 
the INTERGROWTH-21st website).
To reduce expected value bias, all measurements taken 
at or after 14 weeks and 0 days of gestation were not 
visible on the screen to the ultrasonographer, which was 
achieved for the INTERGROWTH-21st Project by specially 
adapting the ultrasound machine used at all sites (Philips 
HD-9 [Philips Ultrasound, Bothell, WA, USA] with 
curvilinear abdominal transducers C5-2, C6-3, V7-3).14 All 
ultrasound data were submitted electronically to the 
study’s database. After each set of measurements, 
ultrasonographers scored the quality of their images on 
the basis of standard image-scoring criteria.15,16 Images 
that did not score the maximum amount of points were 
repeated until the best possible score was achieved. The 
training, standardisation, and quality-control methods 
used across all sites are described in detail elsewhere.15 In 
brief, ultrasonographers were recruited on the basis of 
their technical experience, motivation, reliability, and 
ability to speak the local language or languages. They 
underwent rigorous training, consisting of acquisition of 
theoretical knowledge and familiarity with the study 
protocol, ultrasound operations manual, ultrasound 
machine, data collection, and quality-control measures. 
Centralised hands-on training and initial standardisation 
were also done.17 Additionally, site-specific standardisation 
was done at regular intervals by the ultrasound 
quality-control unit to ensure proper use of the ultrasound 
equipment, calibration, and adherence to the protocol. A 
quality-control system was implemented throughout the 
study with two main objectives: assessment of the 
distributions of the three blinded measurements for each 
fetal biometric measure at every scan and construction of 
cumulative sum charts; and assessment of the quality of a 
random 10% sample of all ultrasound images by the 
centralised ultrasound quality-control unit using a 
validated scoring system, and remeasurement of these 
images.15 Only after three measurements of each structure 
were recorded were the average values revealed to the 
operator for clinical purposes.
All documentation used in the INTERGROWTH-21st 
Project was tested locally and introduced into the 
specially developed, online electronic data entry, cleaning, 
and management system developed by MedSciNet UK 
(London, UK). Data were entered locally directly onto the 
web-based system.18 During data cleaning, we excluded 
14 head circumference, six biparietal diameter, 
two occipitofrontal diameter, 14 abdominal circum-
ference, and seven femur length measurements because 
they were regarded as implausible on the basis of all 
sites’ gestational age distribution or were more than 
5 SDs of all sites’ gestational age-specific mean.
Statistical analysis
The sample size was based on pragmatic and statistical 
considerations; the latter focused on the precision and 
accuracy of one extreme centile—ie, the 3rd or 97th 
centile, and regression-based reference limits.19,20 We 
have shown that a sample of 4000 women would obtain 
precision of 0·03 SD at the 3rd or 97th centile. Further 
details on the precision obtained at the 5th or 10th 
centiles by sample size (ranging from 500 to 6000) were 
See Online for appendix
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included in a table in a previous publication.21 Our target 
was a sample of, on average, 500 pregnant women per 
study site, after excluding complicated pregnancies and 
those lost to follow-up. This sample size is larger than 
most previous longitudinal studies and was considered 
feasible and adequate to explore site-specific differences 
or subgroups of about 10% of the whole study if needed.
We expected that, overall, less than 3% of participants 
would be lost to follow-up, and that another 3% would 
be excluded (using criteria decided a priori) from the 
study population because of fetal deaths or congenital 
abnormalities. We also planned to exclude mothers 
diagnosed with very severe medical disorders (eg, 
cancer or HIV) during the index pregnancy, those with 
severe unanticipated pregnancy-related disorders 
needing hospital admission (eg, eclampsia or severe 
pre-eclampsia), and those identified during pregnancy 
who no longer fulfilled all the entry criteria (eg, women 
who started smoking during pregnancy or had an 
episode of malaria). The decision to pool the data from 
all the study sites to construct the fetal growth standards 
was based on the detailed analyses done using the 
strategy that was recommended in the WHO MGRS; 
the results are described in detail elsewhere.10 The 
statistical methods used to construct the fetal standards 
from this pooled sample were based on the 
recommendations of Altman and Chitty22 and Royston 
and Altman,23 complemented by recent scientific 
literature reviews24,25 and our systematic review of the 
methods used in previous ultrasound studies aimed at 
creating references of fetal size.26 Our overall aim was to 
produce centiles that change smoothly with age and 
maximise simplicity without compromising model fit.
We explored the following statistical methods: mean and 
SD method using fractional polynomials;27 Cole’s lambda 
(λ), mu (µ), and sigma (σ) (LMS) method,28–30 which 
estimates three age-specific parameters (the median [µ], 
coefficient of variation [σ], and a Box-Cox power 
transformation at each gestational age to remove skewness 
[λ], thereby making the data roughly normally distributed); 
the LMST31 (ie, lambda, mu, sigma, assuming Box-Cox 
t distribution) method, which assumes a shifted and scaled 
(truncated) t distribution to take account of skewness and 
leptokurtosis; the LMSP32 (ie, lambda, mu, sigma, 
assuming Box-Cox power exponential distribution) 
method, which assumes a Box-Cox power exponential 
distribution to take account of skewness, platykurtosis, 
and leptokurtosis; and multi-level models33,34 to account for 
repeat measurements. Furthermore, to present the curves, 
we assessed three smoothing techniques: fractional 
polynomials,27 cubic splines,35 and penalised splines.36
After comparing results from the various approaches, 
we found no evidence to support a non-normal 
distribution for a specific gestational age. Thus, more 
complex methods allowing for skewness and kurtosis 
were not needed and the following methods were 
chosen. The best fitting powers for the median head 
circumference, biparietal diameter, occipitofrontal 
diameter, abdominal circumference, and femur length 
were provided by second-degree fractional polynomials 
and further modelled in a multilevel framework to 
account for the longitudinal design of the study. The 
data structure is composed of three levels—ie, 
measurements within occasions within participants. We 
thus fitted a three-level hierarchical model using the 
runmlwin package in Stata.34 To obtain an equation for 
the SD, we modelled the resulting variance components 
from the multilevel model that accounts for the 
between-participant and within-participant correlations 
using fractional polynomials. The SD was modelled on 
the log scale to stabilise variance.
Goodness of fit incorporated visual inspection of overall 
model fit by comparing empirical centiles (calculated per 
completed week of gestation—eg, 38 weeks of gestation is 
equal to 38 weeks and 0 days to 38 weeks and 6 days of 
gestation) to the fitted centiles, using quantile-quantile 
(q-q) plot of the residuals, plots of residuals versus fitted 
values, and the distribution of fitted Z scores across 
gestational ages. Adjusting for correlated data within 
fetuses has a well known effect of making fitted centiles 
slightly narrower by reducing random error;37,38 therefore, 
we would expect the fitted centiles to be slightly narrower 
than empirical ones. All analyses were done in R statistical 
software39 using the Generalised Additive Models for 
Location, Scale and Shape (GAMLSS) framework40,41 and 
Stata, version 11.2, software.
Tables containing mean and SD, centile values, and 
Z scores by gestational age, expressed in completed weeks 
of gestation (as recommended by WHO International 
Statistical Classification of Diseases and Related Health 
Problems 10th Revision), as well as printable charts will 
be available free on the INTERGROWTH-21st website. A 
tool to calculate the individual centiles and Z scores by 
gestational age (in exact weeks and days) will also be 
available free on the same website by December, 2014.
Role of the funding source
The funders had no role in the study design, data 
collection, data analysis, data interpretation, or writing of 
the report. JV, ATP, EOO, FCB, DGA, CGV and SHK had 
access to the full raw dataset. The corresponding author 
had full access to all of the data and the final responsibility 
to submit for publication.
Results
We screened 13 108 pregnant women attending the 
study clinics at less than 14 weeks and 0 days of 
gestation within the project’s defined geographical 
areas, of whom 4607 (35%) met the eligibility criteria, 
provided consent, and were enrolled (figure 1). The 
most common reasons for ineligibility were low 
maternal height (1022 [12%] of 8501 ineligible patients), 
BMI 30 or higher (1009 [12%]), and maternal age 
younger than 18 years or older than 35 years (915 [11%]). 
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The contribution of each site to the total study 
population ranged from 311 (7%) of 4607 in the USA to 
640 (14%) in the UK. A detailed description of each 
site’s population and their characteristics have been 
presented before.9,10 36 (<1%) women who developed 
severe disorders during pregnancy or took up smoking 
or used drugs were excluded, and 71 (2%) were lost to 
follow-up or withdrew consent. 4422 (96%) women 
delivered a live singleton, of whom 4321 (98%) were 
born without congenital malformations; their 
longitudinal fetal growth data were used to construct 
the fetal standards reported here.
A detailed description of the environmental 
characteristics and working conditions in each 
geographical area have been presented elsewhere.11 The 
results of a survey using a data collection form specifically 
developed for the project showed that most women were 
not exposed to environmental hazards (eg, pollution, 
domestic smoke due to tobacco smoking or cooking, 
radiation, or any other toxic substances) that could affect 
pregnancy outcomes; housing conditions were as 
expected for relatively affluent populations in these 
communities in terms of size, water, sanitation, and 
construction characteristics.11
The baseline characteristics of the study cohort across 
the eight sites were very similar, which was expected 
because women were selected from the underlying 
low-risk populations using the same clinical and 
demographic criteria.10 Table 1 shows the pregnancy and 
perinatal events for the complete cohort, which 
confirmed their status as healthy, well nourished women 
at low risk of impaired fetal growth.
The median number of ultrasound scans (excluding the 
dating scan) in all women was 5·0 (range 1–7; mean 4·9 
[SD 0·8]) and 3976 (92%) women had four or more scans; 
of these 3976 women, the mean number of ultrasound 
scans was 5·0 (SD 0·6; range 4–7), suggesting that 
participants adhered well to the protocol. 17 261 (85%) of 
the 20 313 ultrasound scans were done within the expected 
gestational age window of the protocol (ranging from 
2060 [76%] of 2707 in India to 2803 [93%] of 3006 in Oman).
The gestational age-specific observed and smoothed 
centiles for head circumference, biparietal diameter, 
occipitofrontal diameter, abdominal circumference, and 
Pregnancies 
(n=4321)
Maternal age, years 28·4 (3·9)
Maternal height, cm 162·2 (5·8)
Maternal weight, kg 61·3 (9·1)
Paternal height, cm 174·4 (7·3)
Body-mass index, kg/m² 23·3 (3·0)
Gestational age at first visit, weeks 11·8 (1·4)
Years of formal education, years 15·0 (2·8)
Haemoglobin level at <15 weeks, g/L 125 (11)
Married or cohabiting 4204 (97%)
Nulliparous 2955 (68%)
Pre-eclampsia 31 (<1%)
Pyelonephritis 16 (<1%)
Any sexually transmitted infection 3 (<1%)
Spontaneous initiation of labour 2868 (66%)
PPROM (<37 weeks) 80 (2%)
Caesarean section 1541 (36%)
NICU admission >1 day 240 (6%)
Preterm (<37 weeks) 195 (5%)
Preterm and spontaneous onset of labour 126 (3%)
Term LBW (<2500 g; ≥37 weeks) 128 (3%)
Neonatal mortality 7 (<1%)
Male sex 2149 (50%)
Exclusive breastfeeding at discharge 3786 (88%)
Mother admitted to intensive care unit 17 (<1%)
Birthweight (≥37 weeks), kg 3·3 (0·4)
Birth length (≥37 weeks), cm 49·4 (1·9)
Birth head circumference (≥37 weeks), cm 33·9 (1·3)
Data are mean (SD) or number (%). Maternal baseline characteristics were 
measured at less than 14 weeks of gestation. PPROM=preterm prelabour rupture 
of membranes. NICU=neonatal intensive care unit. LBW=low birthweight. 
Table 1: Baseline characteristics and perinatal events of the Fetal Growth 
Longitudinal Study
4500 women with pregnancy 
 and delivery information
4422 livebirths
4321 livebirths without 
 congenital malformation
included in analysis
101 livebirths with congenital
 malformation*
4607 women enrolled in FGLS
8501 women ineligible at 
 screening or by ultrasound
71 lost to follow-up or 
 withdrew consent
13 108 women interviewed
78 miscarriages, terminations, 
 and stillbirths
36 excluded:
 29 severe maternal 
   disorders
  6 smoking
  1 recreational drugs
Figure 1: Fetal Growth Longitudinal Study (FGLS) flow chart
*Congenital malformations diagnosed by ultrasound during pregnancy or at 
birth by clinical examination.
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Figure 2: Fitted 3rd, 50th, and 97th smoothed centile curves of fetal measurements
Fitted 3rd (bottom dashed line), 50th (middle dashed line), and 97th (top dashed line) smoothed centile curves for fetal head circumference (A), fetal biparietal 
diameter (B), fetal occipitofrontal diameter (C), fetal abdominal circumference (D), and fetal femur length (E) measured by ultrasound according to gestational age. 
Open red circles show empirical values for each week of gestation and open grey circles show actual observations.
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Figure 3: 3rd, 10th, 50th, 90th and 97th smoothed centile curves
Fetal head circumference (A), fetal biparietal diameter (B), fetal occipitofrontal diameter (C), fetal abdominal circumference (D), and fetal femur length (E) measured 
by ultrasound according to gestational age.
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femur length are presented in figure 2. Similarities 
between smoothed centile curves (3rd, 50th, and 97th 
centiles) and observed values were assessed by 
gestational age-specific comparisons. The comparisons 
show excellent agreement between the smoothed and 
empirical centiles.
Overall, the mean differences between smoothed and 
observed centiles for the 3rd, 50th, and 97th centiles, 
respectively, were small: 2·25 mm (SD 3·0), 0·02 mm 
(3·0), and –2·69 mm (3·2) for head circumference 
(figure 2A); 0·83 mm (0·9), –0·05 mm (0·8), and 
–0·84 mm (1·0) for biparietal diameter (figure 2B); 
0·63 mm (1·2), 0·04 mm (1·1), and –1·05 mm (1·3) for 
occipitofrontal diameter (figure 2C); 2·99 mm (3·1), 
0·25 mm (3·2), and –4·22 mm (3·7) for abdominal 
circumference (figure 2D); and 0·62 mm (0·8), 
0·03 mm (0·8), and –0·65 mm (0·8) for femur length 
(figure 2E).
The 3rd, 5th, 10th, 50th, 90th, 95th, and 97th fitted 
centile curves for head circumference, biparietal 
diameter, occipitofrontal diameter, femur length, and 
abdominal circumference according to gestational age, 
which represent the international standards for fetal 
growth, are presented in figure 3. The corresponding 
equations for the mean and SD from the multilevel 
regression models for each measure are presented in 
table 2, allowing for calculations by readers of any 
desired centiles according to gestational age in exact 
weeks. For example, centiles can be calculated as 
mean ± Z × SD, where Z is –1·88, –1·645, –1·28, 0, 1·28, 
1·645, and 1·88 for the 3rd, 5th, 10th, 50th, 90th, 95th, 
and 97th centiles, respectively. The actual values for 
these centiles according to gestational age are presented 
in the appendix.
Discussion
To describe optimal fetal growth for singleton 
pregnancies, the INTERGROWTH-21st Project used a 
prescriptive approach42 to select a population of healthy, 
well nourished pregnant women and their fetuses and 
newborn babies, following the recommendation of the 
special 1995 WHO Expert Committee43 and implemented 
by the WHO MGRS for infants and children.7 This meant 
studying a cohort of prospectively enrolled women whose 
risk of adverse maternal and perinatal outcomes 
(including fetal growth restriction) was low according to 
their individual clinical profiles and the socioeconomic 
and demographic characteristics of the underlying 
eight geographically diverse populations.
From this population, we have generated the first 
international standards (as opposed to references) for 
fetal growth using the complete FGLS sample of 4321 live 
singletons without congenital malformations, whose 
healthy status has been confirmed by close follow-up of 
the pregnancies, assessment of the neonates, and in 
accordance with examination of their growth, nutrition, 
and gross motor development at age 1 year.
Remarkably, at birth and age 1 year, the infants included 
in the international fetal growth standards presented here 
were very similar to those enrolled in the WHO MGRS, 
whose data were used to construct the infant and child 
growth standards that have now been adopted by more 
than 140 countries. For example, the mean birth length at 
more than 37 weeks and 0 days of gestation in the WHO 
MGRS was 49·5 cm (SD 1·9), compared to 49·4 cm (1·9) 
in the INTERGROWTH-21st cohort, and the mean 
birthweight in the WHO MGRS was 3·3 kg (0·5), which 
was virtually identical to ours 3·3 kg (0·4). Moreover, very 
reassuringly, at age 1 year, the FGLS cohort was on the 
49th and 52nd centiles for length and the 49th and 50th 
centiles for head circumference (for boys and girls, 
respectively) of the WHO Child Growth Standards.
Therefore, the international fetal growth standards 
presented here contribute some crucial components to 
the care of pregnant women and their children: a unique 
set of clinical tools for use across all health-care systems 
to diagnose fetal growth restriction uniformly and 
monitor growth from early pregnancy, through the 
neonatal period to age 5 years, founded on the same 
conceptual and methodological approach and age-specific 
cutoff points.
We believe these standards, as opposed to the several 
locally produced references in use worldwide,4 have the 
potential to improve pregnancy outcomes,44 not least 
because at present the diagnosis of fetal growth 
restriction is made at different levels of care, even within 
the same regions or countries, using different fetal 
growth charts and cutoff points—ie, fetuses can be 
classified as growth restricted in one part of a city or 
country and of healthy size in another. This leads to 
inaccuracy in diagnosis and ultimately unnecessary, or 
an absence of, appropriate interventions. Additionally, 
Regression equation
Head circumference
Mean −28·2849 + 1·69267 × GA² − 0·397485 × GA² × log (GA)
SD 1·98735 + 0·0136772 × GA³ − 0·00726264 × GA³ × log (GA) + 0·000976253 × GA³ × log (GA)²
Biparietal diameter
Mean 5·60878 + 0·158369 × GA² − 0·00256379 × GA³
SD exp (0·101242 + 0·00150557 × GA³ − 0·000771535 × GA³ × log (GA) + 0·0000999638 × GA³ × log (GA)²)
Occipitofrontal diameter
Mean −12·4097 + 0·626342 × GA² − 0·148075 × GA² × log (GA)
SD exp (−0·880034 + 0·0631165 × GA² − 0·0317136 × GA² × log (GA) + 0·00408302 × GA² × log (GA)²)
Abdominal circumference
Mean −81·3243 + 11·6772 × GA − 0·000561865 × GA³
SD −4·36302 + 0·121445 × GA² − 0·0130256 × GA³ + 0·00282143 × GA³ × log (GA)
Femur length
Mean −39·9616 + 4·32298 × GA − 0·0380156 × GA²
SD exp (0·605843 − 42·0014 × GA–² + 0·00000917972 × GA³)
All log are natural logarithms. GA=exact gestational age.
Table 2: Equations for the estimation of the mean and SD (in mm) of each fetal biometry measurement 
according to exact gestational age (in weeks)
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use of fetal growth standards derived from a healthy 
population reduces the risk of underdiagnosing fetal 
growth restriction, which can occur when the fetus is 
monitored against references that include high-risk 
mothers (panel).
The existing fetal growth references have some major 
limitations, which were identified in a systematic review.4 
They include retrospective design; use of routinely 
obtained measurements; suboptimal pregnancy dating 
strategies; absence of prospective ultrasound quality 
control, standardisation, and calibration of equipment; 
hospital-based sampling; absence of sampling from a 
healthy, well nourished, underlying population; and no 
blinding of measurements.4 In view of these limitations 
and the reference nature of their design (ie, they are related 
to a given place and time), the identification of fetuses with 
growth restriction is, not surprisingly, problematic. 
Additionally, the choice of reference chart to be used is 
often based on local preference, or simply on the chart that 
is loaded into the ultrasound machine software. However, 
the choice has major clinical implications. For example, 
the proportion of fetuses classified as having a biparietal 
diameter below the 5th centile at 20–24 weeks of gestation 
ranged from 6·6% to 23·7% when using three different 
popular ultrasound references.46
Our study9 aimed to avoid these limitations.4 It was truly 
prospective, and we used a population-based sampling 
strategy that initially selected geographical regions where 
a substantial proportion of women are healthy, well 
nourished, educated, and at low risk of fetal growth 
restriction, from which, in a second step, we identified 
pregnant women for FGLS, on the basis of several 
individual clinical and demographic characteristics. The 
ultrasound measurements were taken specifically for the 
purpose of constructing international standards and 
the method was rigorous and implemented across all 
study sites: we standardised the measurement of fetal 
size using centrally trained staff; each study site used the 
same specially adapted ultrasound equipment to allow 
blinding of measurements; more than one measurement 
for each biometric variable was taken at each scan to 
reduce error; and we developed a novel quality-control 
strategy for all ultrasound measurements, including 
assessment of intraobserver and interobserver variability 
at all sites and continual independent image review and 
scoring at a central location where all images were stored 
for independent re-measuring.14,15 Finally, the appropriate 
statistical methods were used to analyse our dataset of 
repeated measurements; hence, we are in effect 
describing true growth.
Unfortunately, not all eligible women from the 
underlying low-risk population were enrolled because of 
the logistical constraints of having only one dedicated 
ultrasound machine at each site for the study. Eligible 
women were recruited consecutively at each antenatal 
clinic in the geographical areas up to a weekly limit 
(about six women per week per site) to avoid 
overwhelming the capacity of the project’s ultrasound 
research team. We believe that the risk of selection bias 
was small, and comparisons show that the FGLS cohort 
was very similar to the corresponding total population of 
women with the same characteristics from which the 
FGLS cohort was obtained.10
The inevitable and recurrent question related to the 
implementation of international, prescriptive growth 
standards (including ours) is whether or not they can be 
generalised to all populations, considering that they 
were generated, in our case, from only eight 
geographically diverse study sites. The answer is that the 
generalisability of anthropometric standards based on 
a prescriptive approach and international sampling 
frames of geographically and ethnically diverse 
populations is supported by the uncertainty surrounding 
the identification of functionally significant, common 
genetic variants that are unique to ethnic groups in 
quantitative, complex traits.47,48 Additionally, we used a 
population-based sample of well nourished participants 
at each of the INTERGROWTH-21st sites—ie, we 
intentionally controlled for well documented adverse 
environmental or socioeconomic conditions that are 
universal constraints on fetal growth, thereby 
considerably reducing a common cause for population-
wide growth differences often observed in diverse 
populations. Furthermore, the empirical data produced 
from the same population showed the similarity from 
early pregnancy to birth of all the fetal and newborn 
skeletal measures across the study sites.10
Panel: Research in context
Systematic review
Ultrasound is widely used worldwide to detect abnormal fetal growth, but its accuracy as 
a test is dependent upon the reliability of the fetal size chart used. A systematic review 
identified 83 observational studies, published from Jan 1, 1968, to Sept 30, 2011, whose 
primary aim was to create such charts. We searched Medline, Embase, and CINAHL for 
studies published in English. A list of search terms used has been published previously.4 
We found 337 studies, which had substantial methodological heterogeneity, and none 
met the WHO recommendations for monitoring fetal anthropometric measurements.7 
The large number of charts available, the reference nature of their design (ie, they are 
related to a given place and time), and the variation in the cutoff points used to define 
abnormal growth, make it difficult in routine clinical practice to identify fetal growth 
restriction (FGR). International standards are, therefore, urgently needed, in keeping with 
those available for children from birth to age 5 years.5,44
Interpretation
From our cohort of healthy, well nourished pregnant women prospectively enrolled from 
eight geographically diverse populations, and whose risk of adverse maternal and perinatal 
outcomes (including FGR) was low, we have generated the first international standards for 
fetal growth based on the primary ultrasound measures of head circumference, biparietal 
diameter, occipitofrontal diameter, abdominal circumference, and femur length, according 
to gestational age. Combined with our newborn standards,45 the new fetal standards are 
for use worldwide to diagnose FGR uniformly and monitor growth from early pregnancy 
through to the neonatal period. We recommend these tools for the interpretation of 
routine ultrasound measurements and comparisons across populations.
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Finally, the cumulative experience gained from 
implementation in more than 140 countries of the WHO 
MGRS standards, which were derived from the 
prescriptive, international study of postnatal growth, and 
whose design and methods were almost identical to the 
INTERGROWTH-21st Project, further supports the 
generalisability of our standards. International growth 
standards can be regarded as close to universal as 
possible and more accurate than other available methods.
We hope that these international fetal growth standards, 
complementing our published standards for early fetal 
linear size,49 in addition to our newborn standards,45 will 
contribute to the recently launched Every Newborn 
Action Plan that focuses on the “development of a 
minimum perinatal dataset with standard metrics for 
counting births, stillbirths, neonatal deaths, birthweight, 
and gestational age”.50
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Those working with pregnant women know the 
situation well: whether a particular unborn baby 
is judged to be too small will partly depend on the 
choice of fetal biometric charts used. Some charts can 
increase the likelihood of finding a fetal measurement 
below a threshold for smallness by fourfold or more.1 
Inconsistent chart use and overestimation of fetal 
smallness can result in cynicism, confusion, and anxiety 
for pregnant women and their caregivers at all stages 
of pregnancy. The stakes are especially high when 
smallness of biometric measures alone raises a red flag 
for aneuploidy, other genetic syndromes such as skeletal 
dysplasia, or fetal developmental abnormalities such 
as microcephaly. In later pregnancy, suspected fetal 
smallness might trigger interventions such as induction 
of labour and caesarean section, with consequent risks, 
including iatrogenic prematurity. Human, pregnancy, 
and financial costs are likely to follow.
However, to miss true fetal growth restriction is 
equally serious because suboptimum birthweight is 
associated with lifelong health disadvantages.2 Most 
pertinent to maternity caregivers is that fetal growth 
restriction is the single biggest risk factor for stillbirth. 
The fourfold increase in stillbirth risk in the growth-
restricted fetus is doubled again in those in whom fetal 
growth restriction is undetected.3 An accepted universal 
standard of fetal size and growth is urgently needed.
Robust methods for fetal biometric chart development 
have been described since the 1990s,4,5 but many 
frequently used charts do not adhere to these standards.6 
Practitioners might not be able to identify and access 
a methodologically superior chart easily, and instead 
default to what is loaded onto their ultrasound machine 
or follow institutional practices, which—clinicians 
acknowledge—can vary according to where the 
practitioner is working on different days of the week.7
The multicentre, population-based Fetal Longitudinal 
Growth Study (FLGS) of the International Fetal and 
Newborn Growth Consortium for the 21st Century 
(INTERGROWTH-21st) Project cuts through the noise with a 
clear signal. Led by researchers from around the world, this 
study has followed the methods of the WHO Multicentre 
Growth Reference Study,8 recruiting more than 4000 
pregnant women from eight countries. Although differing 
in ethnicity, these women were intentionally sampled 
for their shared trait of being at low risk of pregnancy 
complications attributable to malnutrition, obesity, 
socioeconomic deprivation, or major environmental 
pollution. A recent publication from this group came to the 
conclusion that fetuses and newborn infants grow very 
similarly in these eight different research settings.9 
This information is especially valuable for the multi-
cultural societies that now exist in many European, 
International fetal growth standards: one size fits all
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North American, and Australasian countries, which 
are characterised by high rates of immigration and 
intermarriage. To expect all fetuses to have the same 
growth potential irrespective of ethnic origin is simple 
and fair: identification of ethnic origin might not be 
straightforward in multicultural societies, and to adapt 
fetal growth expectations for ethnic origin creates the 
risk of generating an expectation of poorer perinatal 
outcome.10 The latter can detract from efforts to improve 
perinatal outcomes for vulnerable groups. Arguably, 
the most important conclusion that can be drawn from 
the INTERGROWTH-21st Consortium’s findings is that 
recorded intercountry differences in fetal size and growth 
are more indicative of deprivation than geographical 
location. Acceptance of international growth standards 
involves a change in theoretical approach and sets the 
bar for universal aspirational targets of fetal growth. 
 In The Lancet, Aris Papageorghiou and colleagues11 for 
the International Fetal and Newborn Growth Consortium 
for the 21st Century (INTERGROWTH-21st) report FLGS 
charts for fetal biparietal diameter, head circumference, 
occipitofrontal diameter, abdominal circumference, 
and femur length, which were obtained every 5 weeks 
(within 1 week either side) from 14 weeks to 42 weeks of 
gestation. These charts have been developed with great 
care, including sonographer training, quality assurance, 
attention to minimisation of bias, data management, 
and statistical and ethical aspects, which have been 
described previously.12 No issue was too small for 
consideration. For example, questions such as whether 
the biparietal diameter should be measured outer-to-
outer—as in the new FLGS charts—or outer-to-inner 
were discussed with guideline writers, opinion leaders, 
and experienced sonographers, with the final decision 
favouring continuity with postnatal measurements.13
Of particular importance, Papageorghiou and 
colleagues achieved a sample size of 4321, which is 
sufficiently large to produce reliable extreme centiles 
that are of clinical significance. The charts were not 
artificially modified by post-hoc truncation to produce 
a supernormal middle range of measurements such as 
10th–90th centiles, but present aspirational standards 
with valid extreme measurement values. The 3rd, 5th, 
10th, 50th, 90th, 95th, and 97th centile curves were 
calculated according to gestational age for each of the 
five ultrasound measures, representing the international 
standards for fetal growth. The mean differences between 
the observed and smoothed centiles for the clinically 
important 3rd and 97th centiles, respectively, were 
small: 2·25 mm and –2·69 mm for head circumference; 
0·83 mm and –0·84 mm for biparietal diameter; 0·63 mm 
and –1·05 mm for occipitofrontal diameter; 2·99 mm and 
–4·22 mm for abdominal circumference; and 0·62 mm 
and –0·65 mm for femur length. To put these differences 
into context, they are five-to-ten-times smaller than the 
differences between varying charts. 
We strongly encourage fetal medicine, obstetrics, and 
midwifery professional bodies to adopt and endorse 
consistent use of these high-quality, globally relevant 
charts, which give the best available answer to how 
unborn babies should be growing.
*Elizabeth A McCarthy, Susan P Walker
Department of Obstetrics and Gynaecology, Mercy Hospital for 
Women, University of Melbourne, Heidelberg 3084, VIC, Australia 
eamcca@unimelb.edu.au
We declare no competing interests.
1 Salomon LJ, Bernard JP, Duyme M, Buvat I, Ville Y. The impact of choice of 
reference charts and equations on the assessment of fetal biometry. 
Ultrasound Obstet Gynecol 2005; 25: 559–65.
2 Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, 
blood pressure in childhood and adult life, and mortality from 
cardiovascular disease. BMJ 1989; 298: 564–67.
3 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and 
fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108.
4 Altman DG, Chitty LS. Charts of fetal size: 1. Methodology. Br J Obstet Gynaecol 
1994; 101: 29–34.
5 Royston P, Wright EM. How to construct ‘normal ranges’ for fetal variables. 
Ultrasound Obstet Gynecol 1998; 11: 30–38.
6 Ioannou C, Talbot K, Ohuma E, et al. Systematic review of methodology 
used in ultrasound studies aimed at creating charts of fetal size. BJOG 2012; 
119: 1425–39.
7 McCarthy EA, Shub A, Walker SP. Is that femur really short? A survey of 
current and best practice in fetal biometry. Aust N Z J Obstet Gynaecol 2013; 
53: 203–06.
8 Garza C, de Onis M. Rationale for developing a new international growth 
reference. Food Nutr Bull 2004; 25 (1 suppl): S5–S14.
9 Villar J, Papageorghiou AT, Pang R, et al. The likeness of fetal growth and 
newborn size across non-isolated populations in the INTERGROWTH-21 
Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional 
Study. Lancet Diabetes Endocrinol 2014; published online July 7. http://dx.doi.
org/10.1016/S2213-8587(14)70121-4.
10 Li Z, Zeki R, Hilder L, Sullivan EA. Australia’s mothers and babies 2010. 
In: Perinatal statistics. Canberra: AIHW National Perinatal Epidemiology 
and Statistics Unit, 2012.
11 Papageorghiou AT, Ohuma EO, Altman DG, et al, for the International Fetal 
and Newborn Growth Consortium for the 21st Century (INTERGROWTH-
21st). International standards for fetal growth based on serial ultrasound 
measurements: the Fetal Growth Longitudinal Study of the 
INTERGROWTH-21st Project. Lancet 2014; 384: 869–79.
12 Villar J, Altman DG, Purwar M, et al, for the International Fetal and 
Newborn Growth Consortium for the 21st Century. The objectives, design 
and implementation of the INTERGROWTH-21st Project. BJOG 2013; 
120 (suppl 2): 9–26.
13 Cheikh Ismail L, Knight HE, Bhutta Z, Chumlea WC, International Fetal and 
Newborn Growth Consortium for the 21st Century. Anthropometric 
protocols for the construction of new international fetal and newborn 
growth standards: the INTERGROWTH-21st Project. BJOG 2013; 
120 (suppl 2): 42-47.
